Trump's controversial administration nominees signal global ramifications for drug regulation, health funding and pharmaceutical investment.

President-elect Donald J. Trump’s selections to run the nation’s health agencies are alarming infectious disease experts.

President-elect Donald Trump said Tuesday he has selected a Stanford University professor of health policy and skeptic of ...

Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for ...

The Biden administration is attempting to push through a slew of reforms to the controversial MA program in its final months ...

The Biden administration announced Tuesday it’s reinterpreting federal law to allow Medicare and Medicaid patients access to ...

Dr. Jay Bhattacharya Bhattacharya is a physician and professor at Stanford University School of Medicine, and is a critic of ...

UnitedHealth has used algorithms to limit mental health coverage, denying necessary therapy and forcing patients to pay ...

Donald Trump’s health team picks includes outspoken critics of the medical establishment and COVID-19 health measures ...

President-elect Donald Trump has tapped Dr. Jay Bhattacharya, a Stanford health economist and critic of pandemic lo ...

We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a ...

Almost all have been highly critical of the agencies they would run if confirmed, and experts say the nominees represent a ...